Extractables and Leachables Europe 2014, organized by Smithers Rapra, will be coming to Barcelona, Spain on 11-12 November at the Novotel Barcelona City. Following last year's success in London, with an unprecedented number of attendees, this forum will be moving away from the Plastics and Paper in Contact with Foodstuffs event, to its own venue, to provide more room for growth and to allow for targeted networking.
The event will once again provide delegates with a unique opportunity to come together to discuss all current E&L issues facing the pharmaceutical industry, as the programme will feature the latest developments from industry practitioners and working groups to meet regulatory requirements and ensure compatibility in drug-package combinations plus the latest information on regulatory updates, scientific based strategies and practical approaches for the evaluation of extractables and leachables for pharmaceutical packaging materials.
Smithers Rapra are now recruiting papers from experts and companies that have established best practice in the field of extractables and leachables. Organisations presenting a paper at this conference will have the opportunity to present to all parts of the pharmaceutical supply chain and will be firmly positioning themselves at the forefront of E&L activity. Submitted abstracts will be reviewed by the expert programme advisory board, consisting of E&L expert Dr Andrew Feilden at Smithers Rapra, and industry representatives Carsten Worsoe of Novo Nordisk and Thomas Egert at Boehringer Ingelheim.
For more information or to submit a proposed paper title and short abstract, please contact Hayley Marsden, +44(0)1372 802026, firstname.lastname@example.org. The deadline for proposed papers is 13 June 2014.
The following topics will be particularly relevant to the direction of the conference, however all submitted themes will be considered:
- supply chain management;
- toxicology of possible leachables;
- single use systems;
- risk assessment methodologies relating to E&L strategies.
- detection limits;
- application of E&L to QC testing programs;
- restricted and regulated substance compliance
- E&Ls and biologicals
- manufacture of pharmaceutical packaging and labelling
- improvements in practical correlation of solvent extractions to product conditions of use
- E&Ls in process components and equipment